Skip to main content
SpringerLink
Log in

Drug Prescribing in Hepatobiliary Disease

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Liver disease in man is associated with a variety of pathophysiological processes which may influence the disposition of drugs in several ways. Interpretation of the observed pharmacokinetic changes in liver disease requires an understanding of the relationship between systemic drug clearance (Cls), volume of distribution (Vd)and the elimination half-life [t1/2(β)], i.e. t1/2(β) = 0.693· Vd/Cls.Half-life will be a measure of the fluctuation in drug level one may expect with continued administration of a drug while clearance will determine the dose required to achieve a particular steady state level. Liver disease may affect clearance and volume of distribution and so produce changes in half-life; in addition, alterations in plasma binding of drugs may occur and so influence free (unbound) drug levels. It is also possible that the end organ response, particularly in the case of sedative drugs, may be affected by liver disease.

Other factors such as age, nutrition, smoking, and concomitant drug therapy may also influence drug elimination in patients with liver disease. At the present time, caution should be exercised in prescribing drugs to patients with liver disease and the dose should be titrated to the clinical response. The development of liver function’ tests using model or marker drugs may offer some help to the prescriber in the future and enable a less empirical approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alvin, J.; McHorse, T.; Hoyumpa, A.; Bush, M.T. and Schenker, S.: The effect of liver disease in man on the disposition of phenobarbital. Journal of Pharmacology and Experimental Therapeutics 192: 224–235 (1975).

    PubMed  CAS  Google Scholar 

  • Andreasen, P.B.; Ranek, L.; Statland, B.E. and Tygstrup, N.: Clearance of antipyrine. Dependence of quantitative liver function. Eur. J, clin. Invest 4: 129–134 (1974).

    CAS  Google Scholar 

  • Avant, G.R.; Schenker, S. and Alford, R.H.: The effect of cirrhosis on the disposition and elimination of clindamycin. American Journal of Digestive Diseases 20: 223–230 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Azzollini, F.; Gazzaniga, A.; Lodola, E. and Natangelo, R.: Elimination of chloramphenicol and thiamphenicol in subjects with cirrhosis of the liver. International Journal of Clinical Pharmacology 6: 1059–1065 (1972).

    Google Scholar 

  • Baraona, E.; Orrego, H.M.; Fernandez, O.; Amenabar, E.; Maldonado, E.; Tag, F. and Salinas, A.: Absorptive function of the small intestine in the liver cirrhosis. American Journal of Digestive Diseases 7: 318–330 (1962).

    Article  PubMed  CAS  Google Scholar 

  • Bircher, J.; Kupfer, A.; Gikalov, I. and Preisig, R.: Aminopyrine demethylation measured by breath analysis in cirrhosis. Clinical Pharmacology and Therapeutics 20: 484–492 (1975).

    Google Scholar 

  • Black, M.; Mitchell, J.R.; Zimmerman, H.J.; Ishak, K.G. and Epier, G.R.: Isoniazid-associated hepatitis in 114 patients. Gastroenterology 69: 289–302 (1975).

    PubMed  CAS  Google Scholar 

  • Blaschke, T.F.: Protein binding and kinetics of drugs in liver disease. Clinical Pharmacokinetics 2: 32–44 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Branch, R.A.; Herbert, C.M. and Read, A.E.: Determination of serum antipyrine half-lives in patients with liver disease. Gut 14: 569–573 (1973a).

    Article  PubMed  CAS  Google Scholar 

  • Branch, R.A.; James, J. and Read, A.E.: The clearance of antipyrine and indocyanine green in normal subjects and in patients with liver disease. Clinical Pharmacology and Therapeutics 20: 81–89 (1976a).

    PubMed  CAS  Google Scholar 

  • Branch, R.A.; James, J. and Read, A.E.: A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. British Journal of Clinical Pharmacology 3: 243–249 (1976b)

    Article  PubMed  CAS  Google Scholar 

  • Branch, R.A.; Morgan, M.H.; James, J. and Read, A.E.: Intravenous administration of diazepam in patients with chronic liver disease. Gut 17: 975–983 (1976c).

    Article  PubMed  CAS  Google Scholar 

  • Branch, R.A.; Nies, A.S. and Shand, D.G.: The disposition of propranolol. VIII. General implications of the effects of liver blood flow on elimination from perfused rat liver. Drug Metabolism and Disposition 1: 687–690 (1973b).

    PubMed  CAS  Google Scholar 

  • Breen, K.J.; Desmond, P.V.; Bury, R. Calder, I. and Mashford, M.L.: A l4C-phenacetin breath test in the assessment of hepatic function. Gastroenterology 72: 1033 (1977).

    Google Scholar 

  • Breimer, D.D.: in Pharmacokinetics of Hypnotic Drugs, pp.291–307 (Drukkerij-Vitgeverij Brakkenstein, Nijmegen 1974).

    Google Scholar 

  • Briant, R.H.: Dorrington, R.E.; Creal, J. and Williams, F.M.: Rate of acetaminophen metabolism in the elderly and the young. Journal of American Geriatrics Society 24: 359–361 (1976).

    CAS  Google Scholar 

  • Brodie, B.B.: Burns, J.J. and Weiner, M.: Metabolism of drugs in subjects with Laennec’s cirrhosis. Medicina Experimentalis 1: 290–292 (1959).

    PubMed  CAS  Google Scholar 

  • Burnett, D.A.; Barak, A.J.; Tuma, D.J. and Sorrell, M.F.: Altered elimination of antipyrine in patients with acute viral hepatitis. Gut 17: 341–344 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Castleden, CM.; George, C.F.; Marcer, D. and Hallett, C: Increased sensitivity to nitrazepam in old age. British Medical Journal 1: 10–12 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Conney, A.H.; Pantuck, E.J.; Kuntzman, R.; Kappas, A.; Anderson, K.E. and Alvares, A.P.: Nutrition and chemical biotransformations in man. Clinical Pharmacology and Therapeutics 22: 707–720 (1977).

    PubMed  CAS  Google Scholar 

  • Crooks, J.; O’Malley, K. and Stevenson, I.H.: Pharmacokinetics in the elderly. Clinical Pharmacokinetics 1: 280–296 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Davis, M. and Rossouw, J.E.: Drug metabolism in liver disease; in Grahame-Smith (Ed.), Drug Interactions, pp. 197–207 (University Park Press, Baltimore 1977).

    Google Scholar 

  • Dvorchik, B.H. and Vesell, E.S.: Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clinical Chemistry 22: 868–878 (1976).

    PubMed  CAS  Google Scholar 

  • Farrell, G.C; Cooksley, W.G.E.; Powell, L.W. and Hart, P.: Interaction between liver disease and chronic drug ingestion on hepatic drug metabolism. Gastroenterology 71: 905 (1976).

    Google Scholar 

  • Fessell, J.M. and Conn, H.O.: An analysis of the causes and prevention of hepatic coma. Gastroenterology 62: 191 (1972).

    Google Scholar 

  • Finlayson, N.D.C; Prescott, L.F.; Adjepon-Yamoiah, K.K. and Forrest, J.A.H.: Antipyrine, lidocaine and paracetamol metabolism in chronic liver disease. Gastroenterology 67: 790 (1974).

    Google Scholar 

  • Hammar, C.H. and Prellwitz, W.: Die glucuronid-bildung nach perorder belastung mit acetanilid bei chronischer hepatitis und lebercirrhose. Klinische Wochenschrift 44: 1010–1014 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Hayes, M.J.; Langman, M.J.S. and Short, D.H.: Changes in drug metabolism with increasing age. 2. Phenytoin clearance and protein binding. British Journal of Clinical Pharmacology 2: 73–79 (1975).

    PubMed  CAS  Google Scholar 

  • Held, H.V.; Oldershausen, H.F. and Remnier, H.: Der abban von pentobarbital bei leberschaden. Klinische Wochenschrift 48: 565–567 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Hepner, G.W. and Vesell, E.S.: Assessment of aminopyrine metabolism in man by breath analysis after oral administration of l4C-aminopyrine. New England Journal of Medicine 291: 1384–1388 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Hepner, G.W.; Vesell, E.S.; Lipton, A.; Harvey, H.A.; Wilkinson, G.R. and Schenker, S.: Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant therapy: Diazepam breath test and correlation in drug elimination. Journal of Laboratory and Clinical Medicine 90: 440–456 (1977).

    PubMed  CAS  Google Scholar 

  • Hoffman, T.A.; Cestero, R. and Bullock, W.E.: Pharmacodynamics of carbenicillin in hepatic and renal failure. Annals of Inmjl Medicine 73: 173–178 (1970).

    CAS  Google Scholar 

  • Hvidberg, E.F.; Andreasen, P.B. and Ranek, L.: Plasma half-life of phenylbutazone in patients with impaired liver function. Clinical Pharmacology and Therapeutics 15: 171–177 (1974).

    PubMed  CAS  Google Scholar 

  • Kato, R.; Oshima, T. and Tomizawa, S.: Toxicity and metabolism of drugs in relation to dietary protein. Japanese Journal of Pharmacology 18: 356–366 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Klotz, U.; Antonin, K.H. and Bieck, P.R.: Comparison of the pharmacokinetics of diazepam after single and subchronic doses. European Journal of Clinical Pharmacology 10: 121–126 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Klotz, U.; Antonin, K.H.; Brugel, H. and Bieck, P.R.: Disposition of diazepam and its major metabolite desmethyldiazepam in patients with liver disease. Clinical Pharmacology and Therapeutics 21: 430–436 (1977).

    PubMed  CAS  Google Scholar 

  • Klotz, U.; Avant, G.R.; Hoyumpa, A.; Schenker, S. and Wilkinson, G.R.: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. Journal of Clinical Investigation 55: 347–359 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Klotz, U.; McHorse, T.S.; Wilkinson, G.R. and Schenker, S.: The effect of cirrhosis on the disposition and elimination of meperidine in man. Clinical Pharmacology and Therapeutics 16: 667–675 (1974).

    PubMed  CAS  Google Scholar 

  • Koch-Weser, J. and Sellers, E.M.: Drug therapy: Binding of drugs to serum albumin. New England Journal of Medicine 294: 311–316 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Kraus, J.W.; Marshall, J.P.; Johnson, R.; Wilkinson, G.R. and Schenker, S.: Lorazepam elimination in liver disease, Gastroenterology 73: 1228 (1977).

    Google Scholar 

  • Kunin, CM.; Glazko, A.J. and Finland, M.: Persistence of antibiotics in the blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis. Journal of Clinical Investigation 38: 1498–1508 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Laidlaw, J.; Read, A.E. and Sherlock, S.: Morphine tolerance in hepatic cirrhosis. Gastroenterology 40: 389–396 (1961).

    PubMed  CAS  Google Scholar 

  • Levi, A.J.; Sherlock, S. and Walker, D.: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1: 1275–1279 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Lewis, G.P.; Jusko, W.J.; Burke, C.W. and Graves, L.: Prednisone side effects and serum protein levels. A collaborative study. Lancet 2: 778–781 (1971).

    Article  PubMed  CAS  Google Scholar 

  • McHorse, T.S.; Wilkinson, G.R.; Johnson, R.F. and Schenker, S.: Effect of acute renal hepatitis in man on the disposition and elimination of meperidine. Gastroenterology 68: 775–780 (1975).

    PubMed  CAS  Google Scholar 

  • Marshall, J.P.; Salt, W.B. Elam, R.O.; Wilkinson, G.R. and Schenker, S.: Disposition of nafcillin in patients with cirrhosis and extrahepatic biliary obstruction. Gastroenterology 73: 1388–1392 (1977).

    PubMed  Google Scholar 

  • Mawer, G.E.; Miller, N.E. and Turnberg, L.A.: Metabolism of amylobarbitone in patients with chronic liver disease. British Journal of Pharmacology 44: 549–560 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Maxwell, J.D.; Carella, M.; Parkes, J.D.; Williams, R.; Mould, G.P. and Curry, S.H.: Plasma disappearance and clinical effects of chlorpromazine in cirrhosis. Clinical Science 43: 143–151 (1972).

    PubMed  CAS  Google Scholar 

  • Mehta, S.; Kalsi, H.K.; Jayaraman, S. and Mathur, V.S.: Chloramphenicol metabolism in children with protein-calorie malnutrition. American Journal of Clinical Nutrition 28: 977–981 (1975).

    PubMed  CAS  Google Scholar 

  • Mitchell, J.R.; Long, M.W.; Thorgeirsson, U.P. and Jollow, DJ.: Acetylation rates and monthly liver function tests during one year of isoniazid preventative therapy. Chest 68: 181–190 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Morgan, M.H. and Read, A.E.: Antidepressants and liver disease. Gut 13: 697–701 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Murray-Lyon, I.; Young, J.; Parkes, J.D.; Knill-Jones, R.P. and Williams, R.: Clinical and electroencephalographic assessment of diazepam in liver disease. British Medical Journal 2: 265–266 (1971).

    Article  Google Scholar 

  • Narang, R.K.; Mehta, S. and Mathur, V.S.: Pharmacokinetic study of antipyrine in malnourished children. American Journal of Clinical Nutrition 30: 1979–1982 (1977).

    PubMed  CAS  Google Scholar 

  • Nation, R.L.; Triggs, E.J. and Selig, M.: Lignocaine kinetics in cardiac patients and aged subjects. British Journal of Clinical Pharmacology 4: 439–448 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Olsen, G.D.; Bennett, W.M. and Porter, G.A.: Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clinical Pharmacology and Therapeutics 17: 677–684 (1975).

    PubMed  CAS  Google Scholar 

  • Powell, L.W.P. and Axelson, E.: Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding. Gut 13: 690–696 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Read, A.E.; Laidlaw, J. and McCarthy, C.F.: Effects of chlorpromazine in patients with hepatic disease. British Medical Journal 1: 497–499 (1969).

    Article  Google Scholar 

  • Richey, D.P. and Bender, A.D.: Pharmacokinetic consequences of aging. Annual Review of Pharmacology and Toxicology 17: 49–65 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Richter, E.; Zilly, W.; Brachtel, D. and Becker, S.: Zur frage der barbituratt-oleranz bei patienten mit akuter hepatitis. Deutsche Medizinische Wochenschrift 97: 254–255 (1972).

    PubMed  CAS  Google Scholar 

  • Roberts, R.K.; Wilkinson, G.R.: Branch, R.A. and Schenker, S.: The effect of age and liver disease on the disposition and elimination of chlordiazepoxide (Librium®). Gastroenterology (In press, 1978).

  • Rowland, M.; Benet, L.Z. and Graham, G.G.: Clearance concepts in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1: 123–136 (1973).

    PubMed  CAS  Google Scholar 

  • Schalm, S.W.; Summerskill, W.H.J. and Go, V.L.W.: Prednisone for chronic active liver disease: Pharmacokinetics, including conversion to prednisolone. Gastroenterology 72: 910–913 (1977).

    PubMed  CAS  Google Scholar 

  • Shideman, F.E.; Kelly, A.R.; Lee, L.E.; Lowell, V.F. and Adams, B.J.: Role of the liver in detoxication of thiopental (pentothal) in man. Anesthesiology 10: 421–428 (1949).

    Article  PubMed  CAS  Google Scholar 

  • Shull, H.J.; Wilkinson, G.R.; Johnson, R. and Schenker, S.: Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Annals of Internal Medicine 84: 420–425 (1976).

    PubMed  CAS  Google Scholar 

  • Snyder, S.H.: Opiate receptors and internal opiates. Scientific American 236: 44–56 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Squires, R.F. and Braestrup, C: Benzodiazepine receptors in rat brain. Nature 266: 732–734 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Vestal, R.E.; Norris, A.H.; Tobin, J.D.; Cohen, B.H.; Shock, N.W. and Andres, R.: Antipyrine metabolism in man: Influence of age, alcohol, caffeine and smoking. Clinical Pharmacology and Therapeutics 18: 425–432 (1975).

    PubMed  CAS  Google Scholar 

  • Weiner, M.; Chenkin, T. and Burns, J.J.: Observations on metabolic transformation and effects of phenylbutazone in subjects with hepatic disease. American Journal of Medical Science 228: 36–39 (1954).

    Article  CAS  Google Scholar 

  • Wilkinson, G.R.: Pharmacokinetics in disease states modifying body perfusion; in Benet (Ed), The Effect of Disease States on Drug Pharmacokinetics, pp. 13–32 (American Pharmaceutical Association, Washington 1976).

    Google Scholar 

  • Wilkinson, G.R. and Schenker, S.: Drug disposition and liver disease. Drug Metabolism Reviews 4: 139–175 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson, G.R. and Shand, D.G.: A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390 (1975).

    PubMed  CAS  Google Scholar 

  • Williams, R.L.; Blaschke, T.F.; Meffin, P.J.; Melmon, K.L. and Rowland, M.: The influence of acute viral hepatitis on lidocaine disposition in man. Clinical Research 23: 226A (1975).

    Google Scholar 

  • Williams, R.L.; Blaschke, T.F.; Meffin, P.J.; Melmon, K.L. and Rowland, M.: Influence of acute viral hepatitis on the disposition of two compound with high hepatic clearance: Lignocaine and indocyanine green. Clinical Pharmacology and Therapeutics 20: 290–299 (1976).

    PubMed  CAS  Google Scholar 

  • Zimmerman, HJ.: Drug-induced liver disease. Drugs 16: 25–45 (1978).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine, Vanderbilt University School of Medicine and Veterans Administration Hospital, Nashville, Tennessee, USA

    R. K. Roberts, P. V. Desmond &  Steven Schenker

Authors
  1. R. K. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. V. Desmond
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven Schenker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roberts, R.K., Desmond, P.V. & Schenker, S. Drug Prescribing in Hepatobiliary Disease. Drugs 17, 198–212 (1979). https://doi.org/10.2165/00003495-197917030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197917030-00005

Keywords

Search

Navigation